China's Ministry of Health said here Tuesday that four deaths had been reported after inoculation of China-made A（H1N1） flu vaccine and three had been confirmed irrelevant to the vaccines.

    The three deaths were "coincidental" and causes of the other death are yet to be finalized, Liang Wannian, director of the ministry's emergency response office, said at a press conference.

    Of the 26.18 million people nationwide who had been vaccinated by Monday, 2,867 suspected adverse reactions had been reported, Liang said. About four fifths of the reactions were fever or swelling.

    "Clinical tests and practices in China and other countries have shown the A（H1N1） flu vaccines are safe," Liang said.

    As of Sunday, the Chinese mainland had reported 178 deaths from the flu. More than 90,000 people were infected and nearly 80 percent had recovered.

    Liang warned that the flu situation in China was still "severe" with an increasing number of deaths and more counties and municipalities reporting confirmed cases.

    The proportion of A（H1N1） flu also increased greatly to about 90 percent of all flu cases in the past weeks.

    Liang said schools were still the main venue for prevention

    中国卫生部星期二说，接种中国制造的A（H1N1）流感疫苗后，有4人死亡，已确认三人的死亡与疫苗无关。

    卫生部应急反应办公室主任梁万年在新闻发布会上说，三例死亡是"巧合",另一例死亡原因有待最后确定。

    梁说，星期一之前，全国共有2千6百1拾8万人接种了疫苗，报告疑似不良反应2867例。其中五分之四为发热和肿胀。

    梁说："中国和其它国家的临床试验和实践表明，A（H1N1）流感疫苗是安全的。"

    截止星期日，中国大陆报告流感死亡人数为178人。9万多人受到感染，近百分之八十已康复。

    梁警告说，中国的流感形势依然"严峻",死亡人数正在增加，越来越多的县和自治区报告确认病例。

    A（H1N1）流感所占比例急剧上长，占过去两星期所有流感病例的90%.

    梁说，学校仍然是预防的重点地区。